Literature DB >> 7663885

Spatial working and reference memory in rats bred for autonomic sensitivity to cholinergic stimulation: acquisition, accuracy, speed, and effects of cholinergic drugs.

P J Bushnell1, E D Levin, D H Overstreet.   

Abstract

Rat lines were selected by breeding for sensitivity to signs of autonomic stimulation (hypotherma, loss of body weight, and reduced water intake) induced by the cholinesterase inhibitor diisopropyl fluorophosphate (DFP). These lines have since been maintained for 10 generations by continued selection for hypothermic responsiveness to the muscarinic agonist oxotremorine. The sensitive rats (Flinders Sensitive Line, FSL) differ from the resistant rats (Flinders Resistant Line, FRL) both neurochemically and behaviorally, particularly in aversively motivated test situations in which response speed is assessed. This study was conducted to determine whether the selected differences in cholinergic autonomic sensitivity would be expressed as differences in cognitive ability based on choice accuracy in appetitive tasks. The working and reference memory of rats of these two strains was thus assessed using operant delayed matching-to-position/visual discrimination (DMTP/VD) and the radial-arm maze. A Long-Evans (L-E) reference group was included in the DMTP/VD study. FSL rats responded more slowly than the other rats during acquisition of both tasks, but showed no differences in response accuracy either during acquisition or during asymptotic performance of either task. In addition, challenges with muscarinic and nicotinic antagonists and agonists [scopolamine (0.06-1.0 mg/kg), pilocarpine (1.0-4.0 mg/kg), mecamylamine (1.0-10.0 mg/kg), and nicotine (0.1-0.3 mg/kg)] demonstrated predicted differences in sensitivity among the lines only on performance measures such as response latency and trial completion. Counter to prediction, the sensitivity of the FRL rats to the ability of scopolamine to reduce matching accuracy was lower than those of the L-E and FSL rats. Thus selection based upon physiological endpoints related to cholinergic autonomic homeostasis did not produce analogous differences in cognitive function in rats.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7663885     DOI: 10.1006/nlme.1995.1012

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  6 in total

1.  2,4-Dithiobiuret in rats: cognitive facilitation after acute injection precedes motor impairment after repeated daily injections.

Authors:  P J Bushnell; W M Oshiro
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

Review 2.  Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression.

Authors:  D H Overstreet; O Pucilowski; A H Rezvani; D S Janowsky
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

3.  Antidepressant-like effects of a novel pentapeptide, nemifitide, in an animal model of depression.

Authors:  David H Overstreet; Joseph Hlavka; John P Feighner; Gabriela Nicolau; Jeffrey S Freed
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

4.  Chronic neuropsychological sequelae of cholinesterase inhibitors in the absence of structural brain damage: two cases of acute poisoning.

Authors:  Lola Roldán-Tapi; Antonia Leyva; Francisco Laynez; Fernando Sánchez Santed
Journal:  Environ Health Perspect       Date:  2005-06       Impact factor: 9.031

5.  Selection of Mice for Object Permanence Cognitive Task Solution.

Authors:  Olga Viktorovna Perepelkina; Inga Igorevna Poletaeva
Journal:  Neurol Int       Date:  2022-08-29

6.  Protective Effects of Pelargonium graveolens Essential Oil on Methomyl-Induced Oxidative Stress and Spatial Working Memory Impairment in Association with Histopathological Changes in the Hippocampus of Male Wistar Rats.

Authors:  Khene M'hammed Amine; Chabane Kahina; Habchi Nawel; Zaida Faiza; Giaimis Jean; Toumi Mohamed; Mameri Saâdia; Baz Ahsene
Journal:  Basic Clin Neurosci       Date:  2020-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.